Location: Tokyo, Japan
CIK: 0002011385 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 13, 2024
Total Value: $132M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 9,194,579 | $108M | 81.2% | $7.85 | +60.4% | COM | 603170101 |
| — | HilleVax, Inc. | 1,208,974 | $17.48M | 13.2% | $16.05 | — | COM | 43157M102 |
| PHAT | Phathom Pharmaceuticals, Inc. | 721,962 | $7.436M | 5.6% | $8.62 | +19.5% | COM | 71722W107 |